CapsoVision (CV) director acquires 2,022 shares through RSU vesting

Rhea-AI Filing Summary

CapsoVision, Inc director Kuo Hui Ying exercised restricted stock units to acquire 2,022 shares of common stock. The RSUs converted at a stated price of $7.58 per share, increasing the director’s direct common stock holdings to 15,263 shares following the transaction.

The RSUs were granted as part of equity incentive awards using a fair market value of $6.18 per share on March 19, 2026. The grant vests 50% of the RSUs on June 30 and 50% on December 31 of the applicable year, and this transaction reflects vesting of one-half of the original grant and receipt of the underlying shares, with 2,023 RSUs remaining outstanding.

Insider Trade Summary

2,022 shares exercised/converted

Mixed 2 txns

Insider Kuo Hui Ying

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit (RSU)	2,022	$0.00	--
Exercise	Common Stock	2,022	$7.58	$15K

Holdings After Transaction: Restricted Stock Unit (RSU) — 2,023 shares (Direct, null); Common Stock — 15,263 shares (Direct, null)

Footnotes (1)

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Key Figures

Shares acquired via RSU exercise: 2,022 shares Transaction price per share: $7.58/share Common shares held after transaction: 15,263 shares +3 more

6 metrics

Shares acquired via RSU exercise 2,022 shares Common Stock from RSU conversion on June 30, 2026

Transaction price per share $7.58/share Stated for common stock acquired on June 30, 2026

Common shares held after transaction 15,263 shares Director’s direct holdings following RSU conversion

Remaining RSUs 2,023 units Restricted Stock Units outstanding after reported vesting

Grant fair market value $6.18/share FMV used for RSU grant on March 19, 2026

RSU vesting schedule 50% June 30, 50% December 31 Annual vesting pattern for the RSU grant

Key Terms

Restricted Stock Unit (RSU), equity incentive grants, fair market value (FMV), vests

4 terms

Restricted Stock Unit (RSU) financial

"Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock."

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

equity incentive grants financial

"were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer"

fair market value (FMV) financial

"utilizing a fair market value (FMV) of a share of the issuers stock of $6.18"

vests financial

"The RSU grant vests as to 50% of the RSUs subject to the award on June 30"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 08:19 PM Accepted by SEC EDGAR 07/01/2026 - 08:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kuo Hui Ying

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/30/2026		M		2,022	A	$7.58	15,263	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit (RSU)	$0	06/30/2026		M			2,022	(2)	(2)	Common Stock	2,022	$0	2,023	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Hui Ying Kuo	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CapsoVision (CV) report for Kuo Hui Ying?

CapsoVision reported that director Kuo Hui Ying exercised restricted stock units to acquire 2,022 shares of common stock. This derivative exercise increased the director’s direct holdings and reflects routine vesting of previously granted equity compensation rather than an open-market stock purchase.

How many CapsoVision (CV) shares does the director hold after this Form 4?

After the RSU conversion, director Kuo Hui Ying directly holds 15,263 shares of CapsoVision common stock. The filing also shows 2,023 restricted stock units remaining outstanding, providing additional potential future share deliveries as those units vest under the grant’s schedule.

What was the size and price of the CapsoVision (CV) RSU exercise?

The director exercised restricted stock units covering 2,022 shares of CapsoVision common stock at a stated transaction price of $7.58 per share. The RSUs themselves carried a conversion price of $0.00, consistent with typical stock-based compensation awards that settle in shares upon vesting.

How were the CapsoVision (CV) RSUs granted and valued?

The restricted stock units were granted as part of CapsoVision equity incentive grants on March 19, 2026, using a fair market value of $6.18 per share. This fair market value benchmark is used to size the award and reflects the issuer’s stock price at the grant date.

What is the vesting schedule for the CapsoVision (CV) RSU award?

The RSU grant vests in two equal installments each year, with 50% of the units vesting on June 30 and the remaining 50% vesting on December 31 of that year. The reported transaction reflects vesting and share delivery for one-half of the original grant.

Did the CapsoVision (CV) insider sell any shares in this Form 4?

The Form 4 shows derivative exercises but no reported sales; both transactions use code M for derivative exercise or conversion. The director acquired 2,022 common shares from RSUs, and there are no open-market sale or tax-withholding disposition codes in this particular filing.